Archive WILEX Ad-hoc- and Press Releases 2009

ENGLISH DEUTSCH

Selected press releases of the former years can be found here.

03 December 2009
AH: WILEX AG closes capital increase
29 November 2009
AH: WILEX AG receives preliminary results of the phase III trial with the diagnostic REDECTANE®

PR: WILEX AG receives preliminary results of the phase III trial with the diagnostic REDECTANE®
25 November 2009
AH: WILEX AG – capital increase: Subscription price for new WILEX shares fixed at EUR 4.10
17 November 2009
AH: WILEX starts Phase I trial for WX-554 and thereby achieves second milestone of the strategic alliance with UCB
11 November 2009
AH: WILEX AG resolves capital increase using authorised capital

13 October 2009
PR: WILEX releases 9-month Financial Report 2009: Significant progress in development projects
02 October 2009
PR: WILEX receives approval for Phase I trial with MEK inhibitor WX-554
29 September 2009
AH: Preliminary data of MESUPRON® show impressive increase in overall survival of patients with pancreatic cancer

PR: Preliminary data of MESUPRON® show impressive increase in overall survival of patients with pancreatic cancer
01 September 2009
PR: Patient recruitment in Phase III registration trial with REDECTANE® successfully completed
04 August 2009
AH: WILEX has filed application for approval of Phase I trial for WX-554 and thereby achieves first milestone of the strategic alliance with UCB

PR: WILEX files application for approval of Phase I trial for WX-554 and achieves first milestone of the strategic alliance with UCB
14 July 2009
PR: WILEX reports on the first half of 2009
08 April 2009
PR: WILEX reports first quarter 2009
02 March 2009
PR: WILEX successfully closes transaction with UCB
19 February 2009
PR: WILEX reports a successful financial year 2008 – positive outlook for 2009
09 January 2009
PR: UCB and WILEX to enter into strategic alliance to develop UCB’s preclinical oncology portfolio
08 January 2009
AH: WILEX strengthens German GAAP equity base with capitalization measures 
AH: UCB and WILEX agree on a strategic alliance
Seite gelesen: 674 | Heute: 2